家
倫理的意思決定支援
哲学/宗教
0
0
功利主義と義務論の枠組みを用いて、複雑なビジネス意思決定の道徳的影響を評価し、コンプライアンスと社会的価値のある行動計画を生成します。
プロンプト内容
コピー
コピー
Act as a senior corporate ethics consultant to deeply analyze the current business decision dilemma using a dual framework of utilitarianism and deontology. First, identify key stakeholders involved and their potential rights infringements, then evaluate the balance between long-term social impacts and short-term commercial benefits of different action plans. Avoid simple binary judgments; instead, provide a structured ethical risk assessment report pointing out potential moral pitfalls and offering optimization suggestions that align with corporate social responsibility standards, ensuring the final plan pursues profit without violating basic human values and legal bottom lines.
コピー
シニア企業倫理コンサルタントとして、功利主義と義務論の二重枠組みを用いて、現在のビジネス意思決定のジレンマを深く分析してください。まず、関与する主要な利害関係者とその潜在的な権利侵害を特定し、次に、異なる行動計画の長期的な社会的影響と短期的な商業的利益のバランスを評価してください。単純な二値判断を避け、潜在的な道徳的罠を指摘し、企業の社会的責任基準に適合する最適化提案を提供する構造化された倫理リスク評価レポートを作成してください。最終的な計画が利益を追求しながら、基本的な人間の価値観と法的底线を違反しないことを確保してください。
コピー
コメント (0)
0/300
おすすめ
倫理的意思決定支援
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers minor but non-fatal side effects during clinical trials that may affect long-term patient quality of life, yet the drug can save thousands of lives with no alternatives. Combine the utilitarian principle of maximizing happiness with the deontological principle of respecting life to analyze whether clinical trials should proceed, and provide balanced advice considering legal compliance, public trust, and patient rights, avoiding absolute moral judgments in favor of a stakeholder-based decision path.
倫理的意思決定支援
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug discovers minor but long-term side effects in clinical trials, while a competitor is about to launch a similar product. Please evaluate whether to disclose data early and delay launch by balancing utilitarian considerations of the greatest good for the greatest number against deontological duties regarding patient informed consent and corporate integrity. Provide a comprehensive report including risk assessment, stakeholder impact analysis, and final action recommendations, ensuring the decision aligns with legal compliance while reflecting the company's social responsibility and long-term values.
倫理的意思決定支援
Act as a senior corporate ethics consultant to conduct a deep moral assessment of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please analyze the trade-offs between disclosing information, adjusting pricing, developing alternatives, and assuming social responsibility by integrating utilitarian impacts on overall well-being with deontological respect for patient autonomy and the principle of non-maleficence. Provide a comprehensive action plan that balances commercial sustainability with moral integrity, focusing on how to protect patient rights while ensuring the company's long-term viability.
倫理的意思決定支援
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks with long-term use, but recalling it would lead to bankruptcy and affect thousands of employees' livelihoods, while concealing it violates patient safety principles. Please evaluate the moral weight of three options—public disclosure, partial recall, or complete concealment—by combining the utilitarian view of the greatest happiness for the greatest number with the deontological view of respecting individual rights and the duty of honesty, and provide a specific action recommendation that balances social responsibility and corporate survival, ensuring the decision-making process is transparent and compliant with business ethics norms.
倫理的意思決定支援
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.
倫理的意思決定支援
Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.
